MoneyWorks4Me

Aurobindo Pharma informs about press release

22 Nov 2023 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release titled ‘Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta™ (Efbemalenograstim alfa Injection) for ChemotherapyInduced Neutropenia (CIN)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..